No abstract available
Keywords:
autism (ASD); clinical research; microbiome; nervous system; neurodegenerative diseases; preclinical models; schizophrenia.
Grants and funding
EH-Y and AF received a joint NHMRC Ideas Grant (APP2003848) and funding from Axial Biotherapeutics. AG was supported by the Else Kröner-Fresenius-Stiftung (214_A251). AF receives support from the La Trobe University Research Focus Area's Food, Water and the Environment funding scheme.